vs
Side-by-side financial comparison of REPLIGEN CORP (RGEN) and Skyward Specialty Insurance Group, Inc. (SKWD). Click either name above to swap in a different company.
Skyward Specialty Insurance Group, Inc. is the larger business by last-quarter revenue ($475.9M vs $194.3M, roughly 2.4× REPLIGEN CORP). Skyward Specialty Insurance Group, Inc. runs the higher net margin — 10.5% vs 4.3%, a 6.2% gap on every dollar of revenue. On growth, Skyward Specialty Insurance Group, Inc. posted the faster year-over-year revenue change (44.8% vs 14.8%). Over the past eight quarters, Skyward Specialty Insurance Group, Inc.'s revenue compounded faster (30.4% CAGR vs 12.3%).
Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...
Skyward Specialty Insurance Group, Inc. is a specialty property and casualty insurance provider offering tailored coverage solutions including commercial auto, general liability, professional indemnity, and specialty property policies. It primarily serves small-to-medium enterprises and niche industry segments across the United States, focusing on underwriting complex, hard-to-place risks for underserved client groups.
RGEN vs SKWD — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $194.3M | $475.9M |
| Net Profit | $8.3M | $49.7M |
| Gross Margin | 55.7% | — |
| Operating Margin | 8.2% | 14.9% |
| Net Margin | 4.3% | 10.5% |
| Revenue YoY | 14.8% | 44.8% |
| Net Profit YoY | 42.9% | — |
| EPS (diluted) | $0.15 | $1.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $194.3M | $475.9M | ||
| Q4 25 | $197.9M | $385.6M | ||
| Q3 25 | $188.8M | $382.5M | ||
| Q2 25 | $182.4M | $319.9M | ||
| Q1 25 | $169.2M | $328.5M | ||
| Q4 24 | $174.1M | $304.4M | ||
| Q3 24 | $154.9M | $300.9M | ||
| Q2 24 | $154.1M | $279.9M |
| Q1 26 | $8.3M | $49.7M | ||
| Q4 25 | $13.3M | $43.2M | ||
| Q3 25 | $14.9M | $45.9M | ||
| Q2 25 | $14.9M | $38.8M | ||
| Q1 25 | $5.8M | $42.1M | ||
| Q4 24 | $-30.3M | $14.4M | ||
| Q3 24 | $-654.0K | $36.7M | ||
| Q2 24 | $3.3M | $31.0M |
| Q1 26 | 55.7% | — | ||
| Q4 25 | 52.5% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 50.0% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 50.0% | — | ||
| Q2 24 | 49.8% | — |
| Q1 26 | 8.2% | 14.9% | ||
| Q4 25 | 9.0% | 14.2% | ||
| Q3 25 | 8.9% | 15.8% | ||
| Q2 25 | 7.6% | 15.6% | ||
| Q1 25 | 3.9% | 15.7% | ||
| Q4 24 | -17.7% | 6.1% | ||
| Q3 24 | -5.1% | 15.6% | ||
| Q2 24 | 1.0% | 14.4% |
| Q1 26 | 4.3% | 10.5% | ||
| Q4 25 | 6.7% | 11.2% | ||
| Q3 25 | 7.9% | 12.0% | ||
| Q2 25 | 8.2% | 12.1% | ||
| Q1 25 | 3.4% | 12.8% | ||
| Q4 24 | -17.4% | 4.7% | ||
| Q3 24 | -0.4% | 12.2% | ||
| Q2 24 | 2.2% | 11.1% |
| Q1 26 | $0.15 | $1.09 | ||
| Q4 25 | $0.24 | $1.03 | ||
| Q3 25 | $0.26 | $1.10 | ||
| Q2 25 | $0.26 | $0.93 | ||
| Q1 25 | $0.10 | $1.01 | ||
| Q4 24 | $-0.55 | $0.33 | ||
| Q3 24 | $-0.01 | $0.89 | ||
| Q2 24 | $0.06 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $582.6M | $4.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $1.2B |
| Total Assets | $2.9B | $6.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $582.6M | $4.1M | ||
| Q4 25 | $767.6M | $168.5M | ||
| Q3 25 | $748.7M | $160.1M | ||
| Q2 25 | $708.9M | $136.6M | ||
| Q1 25 | $697.2M | $112.9M | ||
| Q4 24 | $757.4M | $121.6M | ||
| Q3 24 | $784.0M | $105.6M | ||
| Q2 24 | $809.1M | $73.0M |
| Q1 26 | — | — | ||
| Q4 25 | $542.2M | — | ||
| Q3 25 | $537.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $525.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $2.1B | $1.0B | ||
| Q3 25 | $2.1B | $961.4M | ||
| Q2 25 | $2.1B | $899.9M | ||
| Q1 25 | $2.0B | $850.7M | ||
| Q4 24 | $2.0B | $794.0M | ||
| Q3 24 | $2.0B | $797.5M | ||
| Q2 24 | $2.0B | $723.6M |
| Q1 26 | $2.9B | $6.5B | ||
| Q4 25 | $2.9B | $4.8B | ||
| Q3 25 | $2.9B | $4.6B | ||
| Q2 25 | $2.9B | $4.3B | ||
| Q1 25 | $2.9B | $4.0B | ||
| Q4 24 | $2.8B | $3.7B | ||
| Q3 24 | $2.8B | $3.6B | ||
| Q2 24 | $2.9B | $3.4B |
| Q1 26 | — | — | ||
| Q4 25 | 0.26× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RGEN
| Product | $194.2M | 100% |
| Royalty and other revenue | $44.0K | 0% |
SKWD
Segment breakdown not available.
